Thiram-induced tibial dyschondroplasia (TD) and vitamin-D deficiency rickets are avian bone disorders of different etiologies characterized by abnormal chondrocyte differentiation, enlarged and unvascularized growth plates, and lameness. Heat-shock protein 90 (Hsp90) is a pro-angiogenic factor in mammalian tissues and in tumors, therefore, Hsp90 inhibitors were developed as anti-angiogenic factors. In this study we evaluated the association between Hsp90, hypoxia, and angiogenesis in the chick growth plate.
LONGITUDINAL BONE GROWTH is formed by endochondral ossification that occurs in the growth plates located at the ends of long bones. The resting chondrocytes of the growth plate proliferate slowly and then accelerate their rate of proliferation, divide rapidly along the longitudinal axis of the bone, and form characteristic columns of cells. Ultimately, the most distal cells of the columnar layer stop proliferating, exit the cell cycle, and differentiate into hypertrophic chondrocytes: a change that is characterized by changes in the gene expression profile and by an increase in cell volume. Proliferation and hypertrophy of chondrocytes, along with ECM synthesis, are the main forces of endochondral bone growth (2, 19, 22, 27) . The hypertrophic chondrocytes mineralize their ECM and undergo apoptosis or autophagy, and the area of hypertrophic cartilage, along with bone precursor cells, is invaded by blood vessels (6,7,34,) . The capillary invasion mediated by vascular endothelial growth factor (VEGF) is a key mechanism for the precise coupling of chondrogenesis and osteogenesis that determines the rate of bone growth and is a prerequisite for bone formation (11, 12) . Any changes in this balance might induce pathological conditions, as exemplified by the large numbers of human chondrodysplasias and of transgenic mice (15, 19) . Production of VEGF by the hypertrophic chondrocytes is regulated by hypoxia and by the hypoxia-inducible factor-1α (HIF-1α) (1, 31, 32, 43, 44) . HIF-1α is the major regulator of the hypoxic responses such as chondrocyte growth arrest, survival, maturation, and apoptosis that are essential for chondrogenesis and that mediate oxygen-dependent changes in glucose uptake, increases in red blood cell production, and formation of new blood vessels via angiogenesis (4, 14, 27, 31, 37) . HIF-1α is one of the major client proteins of heat-shock protein 90 (Hsp90), and it is required for the functioning and the rapid hypoxic stabilization of HIF-1α, which otherwise is degraded by the ubiquitinproteasome protein system (17). Hsp90 is implicated in angiogenesis by affecting the VEGF/VEGF-receptor system at various levels (5, 35, 45) and various inhibitors of Hsp90 activity are being evaluated in clinical trials as anti-angiogenic factors (21,29).
Modulation of HIF-1 activity is highly dependent on HSP90 inhibitor concentration.
An increase in HIF-1α protein levels as well as HIF target gene expression such as VEGF was found in the low nanomolar range, whereas higher doses efficiently downregulated the HIF system (16) .
Compared with the mammalian growth plate, the avian one contains much longer columns of chondrocytes, more cells are found in each zone, and the metaphyseal blood vessels penetrate deeply into the growth plate, thereby making the avian growth plate much more vascular than the mammalian one (24,25). Although an oxygenrelated gradient was observed within the chick growth plate, no hypoxia was detected, and the oxygen status of the cells throughout the cartilage was consistent with their oxygen needs (33) . Thiram-induced tibial dyschondroplasia (TD) and vitamin-D deficient rickets (Vit D-) are avian bone disorders characterized by enlarged and unvascularized growth plates, and lameness (3, 26) . The first is the result of copper deficiency; the other is the result of reductions in plasma calcium and phosphorus because of vitamin-D deficiency. Dyschondroplasia was attributed to abnormal differentiation of chondrocytes (26) , to changes in expression of genes encoding VEGF signaling (30) , and to changes in matrix metalloproteinase (MMPs) activities (9, 13) .
In the present study we evaluated the association between Hsp90, hypoxia, and angiogenesis in the chick growth plate. Two growth-plate disorders of dissimilar etiologies and with differing hypoxia status, but both causing a major reduction in vascularization were used. By inhibition of Hsp90 activity and in situ evaluation of chondrocytes differentiation, hypoxia, HIF-1α gene expression, and of the VEGF and its receptor Flk-1 we were able to establish, for the first time, the role of Hsp90 in growth-plate differentiation and vascularization.
MATERIALS AND METHODS

Growth plate disorders and hypoxia determination
Day-old male broiler chicks (Cobb strain) were raised in battery brooders at 24°C. Dyschondroplasia was induced by dietary thiram at 40 ppm in feed from day 3, and rickets by a vitamin D-deficient diet starting at day 1 post-hatch (3). Development of TD lesions (TDL) was verified on day 10. Growth-plate hypoxia was evaluated in situ by injection of Hypoxyprobe (Hypoxyprobe-1, Chemicon International) into the wing vein at 40mg/kg as previously described (10) . In the prevention protocol TD was induced by 40 ppm thiram-containing diet at day 4 post-hatch until day 10 at the time the chicks were sacrificed. The geldanamycin analog 17-DMAG (17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (InvivoGen), a specific inhibitor of Hsp90 activity (39), was administered into the wing vein (600μg) at days 3 (one day before TD induction) and at day 5. Rickets was induced by a vitamin Ddeficient diet from the first day post-hatch and 17-DMAG (600μg) was administered at days 3 and 7 and chicks were sacrificed at day 12. In the treatment protocol, TD was induced by a diet containing 25ppm thiram, 17-DMAG (600μg) was administered at days 7, 10 and 12 post-hatch and chicks were sacrificed at day 14. All control chicks were administered with saline.
This dose was selected based on studies using 17-DMAG to prevent tumor development in mice. All animal experiments were carried out according to the guidelines of the Volcani Center Institutional Committee for Care and Use of Laboratory Animals.
Growth plate sections, immunohistochemistry and in situ hybridization
Immediately after sacrifice by cervical dislocation, the tibiae were fixed in 4% 
Cultured chondrocytes
Primary avian epiphyseal growth-plate chondrocytes prepared as previous described 
Statistical analysis
One-way ANOVA was applied and means were separated by Tukey's test when appropriate. The level of significance used in all results was P < 0.05.
RESULTS
Inhibition of Hsp90, chondrocyte differentiation, and growth-plate histopathology
Dyschondroplasic and vit D-chicks exhibited enlarged and unvascularized growth plates that resulted in abnormal bone growth, reduced BW and lameness ( Fig. 1 and Table 1 ). Administration of 17-DMAG to the TD-afflicted chicks prevented the increase in growth-plate width, which at day 10 did not differ from that of the controls. In addition, BW was partially restored and the chicks regained their ability to stand and walk properly. In the vit D-chicks, although no changes in BW were observed after 17-DMAG administration, the growth plates were significantly smaller and the chicks did not exhibit any signs of lameness. These improvements were probably the result of a local effect of 17-DMAG on growth-plate Hsp90 activity: no changes in plasma calcium (total or ionic), phosphorus or 25-hydroxyvitamin D 3 were observed and bone ash was unaltered (Table 1) . Both disorders are characterized by abnormal differentiation of chondrocytes along the bone axis (Fig. 2) . Collagen type II is synthesized by chondrocytes of the proliferative zone; it is up-regulated in TD, especially above the lesion, and is unaffected in rickets. In the present study, in both cases, collagen type II gene expression was reduced after 17-DMAG treatment and in TD reached control levels. The AP activity that characterizes hypertrophic chondrocytes is absent within the TD lesion, and in rickets chondrocytes that exhibit 
Hsp90 and hypoxia
No hypoxia was observed in the control chicks, and HIF-1α was expressed by chondrocytes of the hypertrophic zone. A major increase in hypoxia was observed in the hypertrophic zone of TD growth-plate together with an increase in the expression of the HIF-1α gene that was especially evident above and below the lesion. In rickets, minor hypoxia was observed only adjacent to blood vessels (Fig. 3) , and HIF-1α was expressed by cells of the lower hypertrophic zone at a lower location along the chondrocyte columns. Treatment with 17-DMAG resulted in elimination of hypoxia in both disorders, and the HIF-1α returned to the control levels.
Addition of 17-AAG, which is a geldanamycine analog and a specific inhibitor of Hsp90 activity to primary cultures of avian growth-plate chondrocytes was associated with decreases in the gene expression of HIF-1α and also of glucose transporter-1 (Glut-1), a downstream gene product of HIF-1α that regulates glucose uptake (Fig.4 ).
Hsp90 and angiogenesis
No changes with respect to the control were observed in the levels of VEGF in the TD-or rickets-afflicted chicks as a result of treatment with 17-DMAG (Fig. 5A ). On the other hand, a significant reduction in the levels of Flk-1 that were observed in both bone disorders was restored after 17-DMAG treatment. Image analysis of the Flk-1 signal revealed a significant reduction (P < 0.05) in the TD and rickets Flk-1 compared with the control (arbitrary units -control 29,125±5,000; TD 17,369±3,300;
vit D-10,205±2,600) and increase back to control levels after 17 DMAG treatment (TD 38,444±5,100 and vit D-22,387±983). As a result, the unvascularized growth plates of TD and vitamin D-deficient chicks were invaded massively by blood vessels and became indistinguishable from the controls (Fig. 5B) .
Inhibition of Hsp90 and established TD
To evaluate the effect of Hsp90 inhibition on chicks with established lesions, chicks were treated for 14 days with thiram starting on day 3 (Fig. 6 ). On day 7 chicks (n = 5) were sacrificed and TD lesions were scored. At this stage all chicks exhibited TD lesions (data not shown). The remaining chicks were divided into two groups, one of which was treated with 17-DMAG on days 7, 10 and 12. On day 14, the thiram- 
DISCUSSION
The avian growth plate is populated by long columns of chondrocytes, and it requires a much higher level of vascularization than the mammalian one in order to provide the tissue with the necessary oxygenation. As a result, the avian growth plate is not hypoxic (Fig. 3) whereas hypoxia is observed in the mammalian one (31 
1, 5). TD and rickets are of dissimilar etiologies in that:
A-levels of plasma calcium, phosphorus and 25(OH)D 3 levels and bone ash are normal in TD, but low in rickets (Table 1) ; B-the PTH/PTHrP axis is not involved in TD whereas in rickets downregulation of the PTH/PTHrP receptor is observed, probably because of high PTH levels (Fig. 2) ; C-the TD lesion is hypoxic, which results in a major increase in HIF-1α gene expression, whereas in rickets only a minor increase in hypoxia is observed, without any changes in HIF-1α expression (Fig. 3) ; On the other hand, both disorders elicit lameness (Fig. 1) , abnormal differentiation of chondrocytes (Fig. 2) , and decreases in Flk-1 levels (Fig. 5A ).
Hsp90 is involved in regulation of protein folding and translocation of proteins across membranes, and it is an important mediator of cell growth, differentiation, survival and angiogenesis (35). Among its clients are pro-angiogenic regulator proteins such as HIF-1α, VEGF, and VEGF receptors. The growth-plate chondrocytes adjacent to the blood-vessels front exhibit HIF-1α (Fig. 4) , and VEGF and Flk-1 (Fig.   5 ). In the normal growth plate HIF-1α is expressed in a hypoxia-independent manner mainly in the hypertrophic zone, where it probably is required for chondrocyte maturation and differentiation (28) . 
